AU2013901514A0 - Formulation and methods for treatment of mental disorders - Google Patents

Formulation and methods for treatment of mental disorders

Info

Publication number
AU2013901514A0
AU2013901514A0 AU2013901514A AU2013901514A AU2013901514A0 AU 2013901514 A0 AU2013901514 A0 AU 2013901514A0 AU 2013901514 A AU2013901514 A AU 2013901514A AU 2013901514 A AU2013901514 A AU 2013901514A AU 2013901514 A0 AU2013901514 A0 AU 2013901514A0
Authority
AU
Australia
Prior art keywords
formulation
treatment
methods
mental disorders
mental
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2013901514A
Inventor
Ian Rochfort
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2013901514A0 publication Critical patent/AU2013901514A0/en
Abandoned legal-status Critical Current

Links

AU2013901514A 2013-04-30 Formulation and methods for treatment of mental disorders Abandoned AU2013901514A0 (en)

Publications (1)

Publication Number Publication Date
AU2013901514A0 true AU2013901514A0 (en) 2013-05-16

Family

ID=

Similar Documents

Publication Publication Date Title
EP3071193A4 (en) Compositions and methods for treatment of ocular inflammation and pain
EP2981326A4 (en) Headset for treatment and assessment of medical conditions
EP2925244A4 (en) Medical device and method of use
IL241191A0 (en) Topical compositions and methods of treatment of topical disorders
EP3038610A4 (en) Compositions and methods for the treatment of presbyopia
EP3024497A4 (en) Methods and compositions for treating brain diseases
SG10201912275YA (en) Use of pyrazolopyrimidine derivatives for the treatment of pi3kd related disorders
EP3038646A4 (en) Diagnostic methods and compositions for treatment of glioblastoma
EP2958936A4 (en) Methods and compositions for treatment of forbes-cori disease
EP3084000A4 (en) Method of diagnosis and treatment
EP2986113A4 (en) Compositions and methods for the treatment of brain injury
EP3013407A4 (en) Medical treatment system and method of use
HK1217896A1 (en) Compositions and methods for the treatment of pervasive development disorders
EP3041577A4 (en) Treatment and prevention of autism and autism spectrum disorders
EP3004396A4 (en) Methods and compositions for the treatment of cancer
EP3068492A4 (en) Neurodegenerative disorders and methods of treatment and diagnosis thereof
EP3068387A4 (en) Compounds and methods for the treatment of malaria
EP3079766A4 (en) Meditation treatment device and method
EP3038707A4 (en) Treatment of pediatric otic disorders
EP3068416A4 (en) Kava derived therapeutic compounds and methods of use thereof
EP3038642A4 (en) Methods of using interleukin-10 for treating diseases and disorders
ZA201408055B (en) Compositions and methods for the treatment of local pain
HK1220374A1 (en) Compositions and methods for the treatment of carboxyhemoglobinemia
EP3082427A4 (en) Compositions and methods for treatment of glaucoma
EP2991733A4 (en) Cannabidiol for the prevention and treatment of graft-versus-host disease